The prevalence of the Ro‐52 autoantibody in our cohort mirrors findings from significant multicentric studies,32 with its positivity previously linked to markedly worse survival rates, PAH, and ILD progression.33, 34. The gene discussed is TRIM21; the disease is pulmonary arterial hypertension.